These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

245 related items for PubMed ID: 17407159

  • 21. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer.
    Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, Brünner N.
    Clin Cancer Res; 2000 Nov; 6(11):4292-9. PubMed ID: 11106246
    [Abstract] [Full Text] [Related]

  • 22. Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
    Diel IJ, Solomayer EF, Seibel MJ, Pfeilschifter J, Maisenbacher H, Gollan C, Pecherstorfer M, Conradi R, Kehr G, Boehm E, Armbruster FP, Bastert G.
    Clin Cancer Res; 1999 Dec; 5(12):3914-9. PubMed ID: 10632320
    [Abstract] [Full Text] [Related]

  • 23. Clinical implications of HER-2/neu overexpression and proteolytic activity imbalance in breast cancer.
    Swellam M, Arab LR, Bushnak HA.
    IUBMB Life; 2007 Jun; 59(6):394-401. PubMed ID: 17613170
    [Abstract] [Full Text] [Related]

  • 24. High levels of messenger RNAs for tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in primary breast carcinomas are associated with development of distant metastases.
    Ree AH, Florenes VA, Berg JP, Maelandsmo GM, Nesland JM, Fodstad O.
    Clin Cancer Res; 1997 Sep; 3(9):1623-8. PubMed ID: 9815852
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tissue inhibitor of matrix metalloproteinase-1 is prognostic in head and neck squamous cell carcinoma: comparison of the circulating and tissue immunoreactive protein.
    Ruokolainen H, Pääkkö P, Turpeenniemi-Hujanen T.
    Clin Cancer Res; 2005 May 01; 11(9):3257-64. PubMed ID: 15867221
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E, Anagnostopoulos K, Tripsianis G, Tentes I, Kakolyris S, Galazios G, Sivridis E, Simopoulos K, Kortsaris A.
    Neoplasma; 2008 May 01; 55(3):229-38. PubMed ID: 18348656
    [Abstract] [Full Text] [Related]

  • 29. Association between tumor tissue TIMP-1 levels and objective response to first-line chemotherapy in metastatic breast cancer.
    Klintman M, Ørnbjerg Würtz S, Christensen IJ, Braemer Hertel P, Fernö M, Malmberg M, Mouridsen H, Cold F, Schrohl AS, Foekens JA, Malmström P, Brünner N.
    Breast Cancer Res Treat; 2010 Jun 01; 121(2):365-71. PubMed ID: 19653096
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Elevated serum levels of a c-erbB-2 oncogene product in oral squamous cell carcinoma patients.
    Chen CH, Lin YS, Lin CC, Yang YH, Ho YP, Tsai CC.
    J Oral Pathol Med; 2004 Nov 01; 33(10):589-94. PubMed ID: 15482324
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Impact of elective resection on plasma TIMP-1 levels in patients with colon cancer.
    Hammer JH, Basse L, Svendsen MN, Werther K, Brünner N, Christensen IJ, Nielson HJ.
    Colorectal Dis; 2006 Mar 01; 8(3):168-72. PubMed ID: 16466554
    [Abstract] [Full Text] [Related]

  • 38. Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with colorectal cancer.
    Yukawa N, Yoshikawa T, Akaike M, Sugimasa Y, Takemiya S, Yanoma S, Imada T, Noguchi Y.
    Anticancer Res; 2004 Mar 01; 24(3b):2101-5. PubMed ID: 15274408
    [Abstract] [Full Text] [Related]

  • 39. Fadrozole HCL (CGS-16949A) versus megestrol acetate treatment of postmenopausal patients with metastatic breast carcinoma: results of two randomized double blind controlled multiinstitutional trials.
    Buzdar AU, Smith R, Vogel C, Bonomi P, Keller AM, Favis G, Mulagha M, Cooper J.
    Cancer; 1996 Jun 15; 77(12):2503-13. PubMed ID: 8640699
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.